Radionuclide therapy, also called molecular radiotherapy (MRT), has come of age, with several novel radiopharmaceuticals being approved for clinical use or under development in the last decade. External beam radiotherapy (EBRT) is a well-established treatment modality, with about half of all oncologic patients expected to receive at least one external radiation treatment over their disease course. The efficacy and the toxicity of both types of treatment rely on the interaction of radiation with biological tissues. Dosimetry played a fundamental role in the scientific and technological evolution of EBRT, and absorbed doses to the target and to the organs at risk are calculated on a routine basis. In contrast, in MRT the usefulness of internal dosimetry has long been questioned, and a structured path to include absorbed dose calculation is missing. However, following a similar route of development as EBRT, MRT treatments could probably be optimized in a significant proportion of patients, likely based on dosimetry and radiobiology. In the present paper we describe the differences and the similarities between internal and external-beam dosimetry in the context of radiation treatments, and we retrace the main stages of their development over the last decades.

Cicone, F., Sjögreen Gleisner, K., Sarnelli, A., Indovina, L., Gear, J., Gnesin, S., Kraeber-Bodéré, F., Bischof Delaloye, A., Valentini, V., Cremonesi, M., The contest between internal and external-beam dosimetry: The Zeno's paradox of Achilles and the tortoise, <<PHYSICA MEDICA>>, 2024; 117 (jan): N/A-N/A. [doi:10.1016/j.ejmp.2023.103188] [https://hdl.handle.net/10807/305457]

The contest between internal and external-beam dosimetry: The Zeno's paradox of Achilles and the tortoise

Indovina, Luca;Valentini, Vincenzo;
2024

Abstract

Radionuclide therapy, also called molecular radiotherapy (MRT), has come of age, with several novel radiopharmaceuticals being approved for clinical use or under development in the last decade. External beam radiotherapy (EBRT) is a well-established treatment modality, with about half of all oncologic patients expected to receive at least one external radiation treatment over their disease course. The efficacy and the toxicity of both types of treatment rely on the interaction of radiation with biological tissues. Dosimetry played a fundamental role in the scientific and technological evolution of EBRT, and absorbed doses to the target and to the organs at risk are calculated on a routine basis. In contrast, in MRT the usefulness of internal dosimetry has long been questioned, and a structured path to include absorbed dose calculation is missing. However, following a similar route of development as EBRT, MRT treatments could probably be optimized in a significant proportion of patients, likely based on dosimetry and radiobiology. In the present paper we describe the differences and the similarities between internal and external-beam dosimetry in the context of radiation treatments, and we retrace the main stages of their development over the last decades.
2024
Inglese
Cicone, F., Sjögreen Gleisner, K., Sarnelli, A., Indovina, L., Gear, J., Gnesin, S., Kraeber-Bodéré, F., Bischof Delaloye, A., Valentini, V., Cremonesi, M., The contest between internal and external-beam dosimetry: The Zeno's paradox of Achilles and the tortoise, <<PHYSICA MEDICA>>, 2024; 117 (jan): N/A-N/A. [doi:10.1016/j.ejmp.2023.103188] [https://hdl.handle.net/10807/305457]
File in questo prodotto:
File Dimensione Formato  
zeno.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 660.08 kB
Formato Adobe PDF
660.08 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/305457
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact